BREWIN DOLPHIN LTD - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 29 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$995
-11.2%
3,9550.0%0.00%
Q2 2020$1,120
+43.8%
3,9550.0%0.00%
Q1 2020$779
-60.6%
3,9550.0%0.00%
Q4 2019$1,978
-31.4%
3,9550.0%0.00%
Q3 2019$2,883
-78.4%
3,955
+28.6%
0.00%
-100.0%
Q2 2019$13,346
-21.0%
3,075
+33.4%
0.00%
-50.0%
Q1 2019$16,896
+26.6%
2,305
+30.2%
0.00%0.0%
Q4 2018$13,3461,7700.00%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q4 2019
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 383,917$192,0000.12%
MEITAV INVESTMENT HOUSE LTD 2,424,516$1,212,0000.09%
Harel Insurance Investments & Financial Services Ltd. 367,326$184,0000.01%
Virtu Financial LLC 114,318$57,0000.01%
ETF MANAGERS GROUP, LLC 302,909$145,0000.01%
Phoenix Holdings Ltd. 144,451$72,0000.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,460,000$730,0000.00%
GSA CAPITAL PARTNERS LLP 22,834$11,0000.00%
Kingsview Wealth Management, LLC 10,875$5,0000.00%
Cutler Group LLC / CA 2,600$1,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders